$8.43
0.030.36%
Última actualización: Nov 26, 12:39 PM
Comments
Loading...
Greenwich LifeSciences Actividad de operaciones con información privilegiada
GLSINASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Greenwich LifeSciences. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Greenwich LifeSciences.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Greenwich LifeSciences Inc los iniciados?
En Greenwich LifeSciences Inc, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders no han reportado ventas en los últimos 30 días, mientras tanto, los insiders han informado haber comprado un total de 12.90K acciones por un valor total de $110.66K.
Compras y ventas recientes notables de información privilegiada
- El noviembre 12, 2025, Snehal Patel, la empresa CEO AND CFO purchased 10.6K acciones por $8.43 cada una.
- El noviembre 4, 2025, Snehal Patel, la empresa CEO AND CFO purchased 2.3K acciones por $9.26 cada una.
Estadísticas de propiedad de Greenwich LifeSciences Inc
Acciones en circulación
13.368M
Acciones en manos de personas con información privilegiada
7.256M
Porcentaje de acciones en manos de personas con información privilegiada
53.2%
Acciones en manos de instituciones
1.113M
Porcentaje de acciones en manos de instituciones
8.04%
Nov 12, 2025 | CEO AND CFO | 10.60K | $8.43 | $89.36K | BUY | 0.19% | 5.58M | Nov 07 | ||
Nov 04, 2025 | CEO AND CFO | 2.30K | $9.26 | $21.30K | BUY | 0.04% | 5.57M | Oct 31 | ||
Apr 29, 2025 | CEO AND CFO | 3.60K | $9.88 | $35.57K | BUY | 0.06% | 5.57M | Apr 25 | ||
Apr 22, 2025 | CEO AND CFO | 5.40K | $8.98 | $48.49K | BUY | 0.10% | 5.57M | Apr 17 | ||
Apr 08, 2025 | CEO AND CFO | 3.60K | $9.10 | $32.76K | BUY | 0.06% | 5.56M | Apr 07 | ||
Apr 07, 2025 | CEO AND CFO | 5.50K | $8.73 | $48.02K | BUY | 0.10% | 5.56M | Apr 04 | ||
Jan 13, 2025 | CEO AND CFO | 2.50K | $12.51 | $31.27K | BUY | 0.05% | 5.55M | Jan 10 | ||
Jan 08, 2025 | CEO AND CFO | 2.90K | $13.58 | $39.39K | BUY | 0.05% | 5.55M | Jan 06 - Jan 07 | ||
Jan 07, 2025 | CEO AND CFO | 3.40K | $12.95 | $44.03K | BUY | 0.06% | 5.55M | Jan 03 | ||
Jan 06, 2025 | CEO AND CFO | 2.00K | $11.97 | $23.94K | BUY | 0.04% | 5.54M | Jan 02 | ||
Jan 03, 2025 | CEO AND CFO | 2.40K | $11.36 | $27.26K | BUY | 0.04% | 5.54M | Dec 31 | ||
Jan 02, 2025 | CEO AND CFO | 3.20K | $11.12 | $35.58K | BUY | 0.06% | 5.54M | Dec 30 | ||
Nov 25, 2024 | VP CLINICAL REG AFFAIRS | 1.00K | $12.91 | $12.91K | BUY | 0.38% | 264.15K | Nov 21 | ||
Sep 30, 2024 | CEO AND CFO | 1.50K | $14.63 | $21.95K | BUY | 0.03% | 5.54M | Sep 26 | ||
Sep 16, 2024 | VP CLINICAL REG AFFAIRS | 800.00 | $13.85 | $11.08K | BUY | 0.30% | 263.15K | Aug 12 | ||
Aug 08, 2024 | CEO AND CFO | 2.00K | $13.81 | $27.62K | BUY | 0.04% | 5.53M | Aug 06 | ||
Aug 07, 2024 | CEO AND CFO | 5.50K | $13.18 | $72.49K | BUY | 0.10% | 5.53M | Aug 05 | ||
Aug 05, 2024 | VP CLINICAL REG AFFAIRS | 1.00K | $15.15 | $15.15K | BUY | 0.38% | 262.35K | Aug 02 | ||
Jul 24, 2024 | CEO AND CFO | 1.50K | $15.89 | $23.84K | BUY | 0.03% | 5.53M | Jul 23 | ||
Jul 22, 2024 | VP CLINICAL REG AFFAIRS | 1.00K | $16.00 | $16.00K | BUY | 0.38% | 261.35K | Jul 18 | ||
Jun 17, 2024 | CEO AND CFO | 174.82K | $14.30 | $2.50M | BUY | 3.27% | 5.53M | Jun 13 | ||
Apr 03, 2024 | CEO AND CFO | 3.00K | $19.08 | $57.24K | BUY | 0.06% | 5.35M | Apr 01 | ||
Mar 26, 2024 | CEO AND CFO | 2.50K | $19.98 | $49.95K | BUY | 0.05% | 5.35M | Mar 22 | ||
Mar 22, 2024 | CEO AND CFO | 1.50K | $17.68 | $26.52K | BUY | 0.03% | 5.35M | Mar 20 | ||
Mar 07, 2024 | CEO AND CFO | 30.50K | $12.49 | $380.94K | BUY | 0.57% | 5.34M | Mar 05 | ||
Mar 06, 2024 | CEO AND CFO | 4.10K | $13.03 | $53.42K | BUY | 0.08% | 5.34M | Mar 04 | ||
Feb 21, 2024 | CEO AND CFO | 10.80K | $11.16 | $120.53K | BUY | 0.20% | 5.34M | Feb 16 | ||
Feb 20, 2024 | CEO AND CFO | 12.70K | $11.07 | $140.59K | BUY | 0.24% | 5.33M | Feb 15 | ||
Nov 14, 2023 | CEO AND CFO | 5.00K | $10.17 | $50.84K | BUY | 0.09% | 5.31M | Nov 10 | ||
Nov 07, 2023 | CEO AND CFO | 3.50K | $9.11 | $31.88K | BUY | 0.07% | 5.31M | Nov 03 | ||
Oct 31, 2023 | VP CLINICAL REG AFFAIRS | 500.00 | $8.57 | $4.29K | BUY | 0.19% | 260.35K | Oct 27 | ||
Oct 30, 2023 | CEO AND CFO | 2.50K | $7.97 | $19.93K | BUY | 0.05% | 5.30M | Oct 26 | ||
Oct 27, 2023 | CEO AND CFO | 2.50K | $7.91 | $19.77K | BUY | 0.05% | 5.30M | Oct 25 | ||
Oct 12, 2023 | CEO AND CFO | 1.00K | $9.07 | $9.07K | BUY | 0.02% | 5.30M | Oct 10 | ||
Oct 05, 2023 | CEO AND CFO | 2.00K | $8.63 | $17.26K | BUY | 0.04% | 5.30M | Oct 04 | ||
Sep 28, 2023 | VP CLINICAL REG AFFAIRS | 600.00 | $8.71 | $5.23K | BUY | 0.23% | 259.85K | Sep 26 | ||
Sep 21, 2023 | CEO AND CFO | 4.00K | $8.95 | $35.80K | BUY | 0.08% | 5.30M | Sep 19 | ||
Sep 13, 2023 | CEO AND CFO | 1.00K | $9.48 | $9.48K | BUY | 0.02% | 5.29M | Sep 11 | ||
Aug 24, 2023 | CEO AND CFO | 1.00K | $9.97 | $9.97K | BUY | 0.02% | 5.29M | Aug 22 | ||
Aug 08, 2023 | CEO AND CFO | 2.00K | $10.55 | $21.10K | BUY | 0.04% | 5.29M | Aug 04 | ||
Jul 25, 2023 | CEO AND CFO | 1.00K | $9.20 | $9.20K | BUY | 0.02% | 5.29M | Jul 21 | ||
Jul 17, 2023 | VP CLINICAL REG AFFAIRS | 250.00 | $9.49 | $2.37K | BUY | 0.10% | 259.25K | Jul 13 | ||
May 18, 2023 | CEO AND CFO | 1.00K | $11.69 | $11.69K | BUY | 0.02% | 5.29M | May 17 | ||
May 02, 2023 | VP CLINICAL REG AFFAIRS | 250.00 | $11.22 | $2.81K | BUY | 0.10% | 259.00K | Apr 28 | ||
Apr 21, 2023 | CEO AND CFO | 7.00K | $11.10 | $77.70K | BUY | 0.13% | 5.29M | Apr 19 | ||
Apr 20, 2023 | CEO AND CFO | 2.00K | $11.12 | $22.24K | BUY | 0.04% | 5.28M | Apr 18 | ||
Apr 12, 2023 | VP CLINICAL REG AFFAIRS | 1.00K | $11.87 | $11.87K | BUY | 0.39% | 258.75K | Apr 11 | ||
Apr 12, 2023 | CEO AND CFO | 5.00K | $12.42 | $62.10K | BUY | 0.09% | 5.27M | Apr 11 | ||
Mar 16, 2023 | VP CLINICAL REG AFFAIRS | 250.00 | $12.71 | $3.18K | BUY | 0.10% | 257.75K | Mar 15 | ||
Mar 13, 2023 | CEO AND CFO | 1.00K | $12.12 | $12.12K | BUY | 0.04% | 2.74M | Mar 10 | ||
Feb 28, 2023 | VP CLINICAL REG AFFAIRS | 250.00 | $15.39 | $3.85K | BUY | 0.10% | 257.50K | Feb 24 | ||
Feb 22, 2023 | CEO AND CFO | 600.00 | $16.53 | $9.92K | BUY | 0.02% | 2.74M | Feb 17 | ||
Feb 14, 2023 | CEO AND CFO | 1.00K | $18.68 | $18.68K | BUY | 0.04% | 2.74M | Feb 10 | ||
Feb 07, 2023 | VP CLINICAL REG AFFAIRS | 250.00 | $20.84 | $5.21K | BUY | 0.10% | 257.25K | Feb 03 | ||
Jan 31, 2023 | CEO AND CFO | 2.00K | $19.35 | $38.70K | BUY | 0.07% | 2.73M | Jan 27 | ||
Jan 30, 2023 | VP CLINICAL REG AFFAIRS | 250.00 | $19.20 | $4.80K | BUY | 0.10% | 257.00K | Jan 27 | ||
Jan 24, 2023 | CEO AND CFO | 1.50K | $17.37 | $26.05K | BUY | 0.05% | 2.73M | Jan 20 | ||
Jan 17, 2023 | VP CLINICAL REG AFFAIRS | 250.00 | $16.50 | $4.13K | BUY | 0.10% | 256.75K | Jan 13 | ||
Jan 10, 2023 | CEO AND CFO | 1.50K | $15.18 | $22.77K | BUY | 0.05% | 2.73M | Jan 06 | ||
Jan 03, 2023 | CEO AND CFO | 4.00K | $15.19 | $60.76K | BUY | 0.15% | 2.73M | Dec 29 | ||
Dec 20, 2022 | CEO AND CFO | 1.00K | $13.01 | $13.01K | BUY | 0.04% | 2.73M | Dec 16 | ||
Dec 20, 2022 | VP CLINICAL REG AFFAIRS | 250.00 | $12.94 | $3.23K | BUY | 0.10% | 256.50K | Dec 16 | ||
Dec 13, 2022 | CEO AND CFO | 2.00K | $13.11 | $26.22K | BUY | 0.07% | 2.72M | Dec 09 | ||
Dec 06, 2022 | CEO AND CFO | 1.00K | $13.84 | $13.84K | BUY | 0.04% | 2.72M | Dec 02 | ||
Dec 06, 2022 | VP CLINICAL REG AFFAIRS | 250.00 | $13.98 | $3.50K | BUY | 0.10% | 256.25K | Dec 02 | ||
Nov 04, 2022 | CEO AND CFO | 2.00K | $8.79 | $17.58K | BUY | 0.07% | 2.72M | Nov 02 | ||
Oct 17, 2022 | CEO AND CFO | 3.00K | $9.75 | $29.25K | BUY | 0.11% | 2.72M | Oct 14 | ||
Oct 11, 2022 | CEO AND CFO | 2.00K | $9.72 | $19.44K | BUY | 0.07% | 2.72M | Oct 07 | ||
Oct 04, 2022 | CEO AND CFO | 1.00K | $9.46 | $9.46K | BUY | 0.04% | 2.71M | Sep 30 | ||
Oct 03, 2022 | CEO AND CFO | 1.00K | $9.23 | $9.23K | BUY | 0.04% | 2.71M | Sep 29 | ||
Jun 27, 2022 | CEO AND CFO | 29.00K | $9.13 | $264.77K | BUY | 1.08% | 2.71M | Jun 24 | ||
Jun 17, 2022 | CEO AND CFO | 8.00K | $7.13 | $57.04K | BUY | 0.30% | 2.68M | Jun 16 | ||
Jun 15, 2022 | CEO AND CFO | 12.00K | $7.91 | $94.92K | BUY | 0.45% | 2.68M | Jun 14 | ||
Jun 13, 2022 | CEO AND CFO | 12.00K | $8.33 | $99.96K | BUY | 0.45% | 2.66M | Jun 10 | ||
Jun 10, 2022 | CEO AND CFO | 4.50K | $10.90 | $49.05K | BUY | 0.36% | 1.24M | Jun 09 | ||
Jun 08, 2022 | CEO AND CFO | 6.00K | $8.55 | $51.30K | BUY | 0.49% | 1.24M | Jun 07 | ||
Jun 06, 2022 | CEO AND CFO | 9.25K | $8.35 | $77.24K | BUY | 0.76% | 1.23M | Jun 03 | ||
Jun 03, 2022 | CEO AND CFO | 6.77K | $7.38 | $49.99K | BUY | 0.56% | 1.22M | Jun 02 | ||
Apr 26, 2022 | CHIEF MEDICAL OFFICER | 1.00K | $16.25 | $16.25K | BUY | 1.12% | 90.12K | Apr 25 | ||
Apr 22, 2022 | CEO AND CFO | 6.00K | $16.09 | $96.54K | BUY | 0.50% | 1.22M | Apr 21 | ||
Apr 21, 2022 | CEO AND CFO | 6.00K | $16.74 | $100.44K | BUY | 0.50% | 1.21M | Apr 19 | ||
Apr 20, 2022 | VP CLINICAL REG AFFAIRS | 500.00 | $16.74 | $8.37K | BUY | 0.20% | 256.00K | Apr 19 | ||
Feb 14, 2022 | CEO AND CFO | 5.50K | $19.80 | $108.90K | BUY | 0.46% | 1.20M | Feb 11 | ||
Feb 08, 2022 | CEO AND CFO | 5.00K | $19.59 | $97.95K | BUY | 0.42% | 1.20M | Feb 04 | ||
Feb 01, 2022 | VP CLINICAL REG AFFAIRS | 500.00 | $18.47 | $9.23K | BUY | 0.20% | 255.50K | Jan 31 | ||
Jan 24, 2022 | VP CLINICAL REG AFFAIRS | 500.00 | $16.33 | $8.16K | BUY | 0.20% | 255.00K | Jan 21 | ||
Jan 24, 2022 | DIRECTOR | 300.00 | $16.32 | $4.90K | BUY | 0.08% | 397.30K | Jan 21 | ||
Jan 19, 2022 | VP CLINICAL REG. AFFAIRS | 500.00 | $18.87 | $9.44K | BUY | 0.20% | 254.50K | Jan 18 | ||
Jan 18, 2022 | CEO AND CFO | 1.00K | $19.99 | $19.99K | BUY | 0.08% | 1.19M | Jan 13 | ||
Jan 14, 2022 | VP CLINICAL REG. AFFAIRS | 1.00K | $19.99 | $19.99K | BUY | 0.40% | 254.00K | Jan 13 | ||
Jan 14, 2022 | CHIEF MEDICAL OFFICER | 1.00K | $19.99 | $19.99K | BUY | 1.13% | 89.12K | Jan 13 | ||
Jan 04, 2022 | CEO AND CFO | 2.05K | $23.82 | $48.83K | BUY | 0.17% | 1.19M | Jan 03 | ||
Dec 16, 2021 | CEO AND CFO | 1.84K | $27.17 | $49.99K | BUY | 0.15% | 1.19M | Dec 14 | ||
Dec 16, 2021 | CHIEF MEDICAL OFFICER | 1.11K | $26.99 | $29.98K | BUY | 1.28% | 88.12K | Dec 14 | ||
Dec 16, 2021 | DIRECTOR | 200.00 | $27.56 | $5.51K | BUY | 0.03% | 620.30K | Dec 14 | ||
Apr 14, 2021 | CEO AND CFO | 2.70K | $36.98 | $99.85K | BUY | 0.11% | 2.52M | Apr 13 | ||
Nov 27, 2020 | — | 1.00K | $5.39 | $5.39K | PURCHASE | 0.25% | 397.00K | Nov 24 | ||
Nov 25, 2020 | — | 1.00K | $5.10 | $5.10K | PURCHASE | 1.16% | 87.01K | Nov 23 | ||
Nov 24, 2020 | — | 1.50K | $5.40 | $8.10K | PURCHASE | 0.24% | 620.10K | Nov 20 | ||
Nov 24, 2020 | — | 1.00K | $5.37 | $5.37K | PURCHASE | 0.25% | 396.00K | Nov 20 | ||
Nov 24, 2020 | — | 2.00K | $5.40 | $10.80K | PURCHASE | 0.64% | 313.23K | Nov 20 | ||
Nov 20, 2020 | — | 2.00K | $5.40 | $10.80K | PURCHASE | 0.08% | 2.52M | Nov 19 | ||
Oct 01, 2020 | — | 16.67K | $4.60 | $76.71K | PURCHASE | 0.67% | 2.51M | Sep 29 | ||
Oct 01, 2020 | — | 8.33K | $4.60 | $38.35K | PURCHASE | 2.16% | 395.00K | Sep 29 | ||
Sep 29, 2020 | — | 74.78K | $5.75 | $430.00K | PURCHASE | 40.96% | 257.37K | Sep 29 | ||
Sep 29, 2020 | — | 114.35K | $5.75 | $657.50K | PURCHASE | 15.26% | 863.68K | Sep 29 | ||
Sep 29, 2020 | — | 1.74K | $5.75 | $10.00K | PURCHASE | 2.06% | 86.01K | Sep 29 | ||
Sep 29, 2020 | — | 2.61K | $5.75 | $15.00K | PURCHASE | 0.59% | 446.98K | Sep 29 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.